Location History:
- Carlsbad, CA (US) (2011 - 2016)
- Asbury, NJ (US) (2014 - 2017)
- Ashbury, NJ (US) (2020 - 2022)
Company Filing History:
5 out of 1,035 
3 out of 271 
1 out of 789 
Years Active: 2011-2022
Title: Innovations by Diane Tribble
Introduction
Diane Tribble is a prominent inventor based in Carlsbad, California, known for her significant contributions to the field of medicine. With a total of nine patents to her name, she has made remarkable advancements in the treatment of hypercholesterolemia and related cardiovascular conditions. Her work focuses on developing antisense compounds that target specific nucleic acids to improve health outcomes.
Latest Patents
Diane's latest patents include innovative methods for treating hypercholesterolemia. These patents disclose antisense compounds and methods aimed at decreasing LDL-C levels in individuals with elevated cholesterol. Additionally, her inventions encompass strategies for treating, preventing, or ameliorating hypercholesterolemia and atherosclerosis. Notably, her methods also address the reduction of coronary heart disease risk through the administration of antisense compounds targeted to PCSK9 nucleic acids. The antisense compounds she has developed include gapmer antisense oligonucleotides, showcasing her commitment to advancing medical treatments.
Career Highlights
Throughout her career, Diane has worked with leading companies in the pharmaceutical industry, including Isis Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. Her experience in these organizations has allowed her to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Diane has collaborated with notable colleagues such as Susan M. Freier and Rosanne M. Crooke. These partnerships have further enhanced her research efforts and have played a crucial role in the success of her inventions.
Conclusion
Diane Tribble's innovative work in the field of medicine, particularly in the treatment of hypercholesterolemia, has made a significant impact on healthcare. Her dedication to developing effective antisense compounds demonstrates her commitment to improving patient outcomes and advancing medical science.